One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?-Reference-Cited by-同舟云学术

One or 3 months dual antiplatelet therapy in high bleeding risk patients: splitting hair or aiming at the bullseye?

Published:2023-11-20 Issue:1 Volume:45 Page:71-72
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Costa Francesco¹^ORCID,Montalto Claudio²,Valgimigli Marco³

Affiliation:

1. Department of Biomedical and Dental Sciences and Morphological and Functional Imaging, University of Messina , A.O.U. Policlinic ‘G. Martino’, via C. Valeria 1 , Messina 98165, Italy

2. De Gasperis Cardio Center, Interventional Cardiology Unit, Niguarda Hospital , Milan , Italy

3. Cardiocentro Ticino Institute and Università della Svizzera Italiana (USI) , Lugano , Switzerland

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

https://academic.oup.com/eurheartj/article-pdf/45/1/71/54877653/ehad729.pdf

Reference5 articles.

1. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials;Costa;Eur Heart J,2023

2. 2023 ESC guidelines for the management of acute coronary syndromes;Byrne;Eur Heart J,2023

3. XIENCE 90 and XIENCE 28 investigators. Duration of dual antiplatelet therapy for patients at high bleeding risk undergoing PCI;Valgimigli;J Am Coll Cardiol,2021

4. Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRACER) randomized trial;Valgimigli;Eur Heart J,2017

5. Dual antiplatelet therapy after PCI in patients at high bleeding risk;Valgimigli;N Engl J Med,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Age Have a Differential Effect on 1 Month Versus 3 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients at High Bleeding Risk?;The American Journal of Cardiology;2024-03

2. The key role of thrombosis: focus on acute coronary syndrome, venous thrombo-embolism, and atrial fibrillation;European Heart Journal;2024-01-01